Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Krasnova

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Arkhiv Patologii|January 1, 1990
[The action of cyclophosphane in different morphological variants of glomerulonephritis in mice]D V Samoĭlov, A A Ivanov, O P Gladskikh, et al.
Terapevticheskii Arkhiv|January 1, 1991
[The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane]T N Krasnova, E M Shilov, A A Ivanov, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|April 21, 2016
[Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers]L M Samokhodskaia, E E Starostina, E B Yarovaya, et al.
Terapevticheskii Arkhiv|January 1, 1993
[The possible approaches to the theoretical validation of the use of cytostatics and corticosteroids in treating glomerulonephritis]A A Ivanov, E M Shilov, O P Gladskikh, et al.
Klinicheskaia Meditsina|August 24, 2006
[Ischemic renal disease: clinical course, prognosis, possibilities of treatment]N A Mukhin, V V Fomin, S V Moiseev, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 7, 2007
[Genetic markers of predisposition to an aggressive course of chronic C hepatitis]S M Abdullaev, Iu I Tselishcheva, L M Samokhodskaia, et al.
Terapevticheskii Arkhiv|January 1, 1997
[Arterial hypertension in lupus nephritis]I E Tareeva, M Iu Shvetsov, T N Krasnova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Study of urinary markers of different podocytopathies by proteomic analysis]A A Vinogradov, N V Chebotareva, A E Bugrova, et al.
Terapevticheskii Arkhiv|July 23, 2013
[Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity]M G Galiamov, E A Saginova, M M Severova, et al.
Terapevticheskii Arkhiv|August 8, 1998
[Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis]T N Krasnova, E M Shilov, I E Tareeva, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Arkhiv Patologii|January 1, 1990
[The action of cyclophosphane in different morphological variants of glomerulonephritis in mice]D V Samoĭlov, A A Ivanov, O P Gladskikh, et al.
Terapevticheskii Arkhiv|January 1, 1991
[The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane]T N Krasnova, E M Shilov, A A Ivanov, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|April 21, 2016
[Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers]L M Samokhodskaia, E E Starostina, E B Yarovaya, et al.
Terapevticheskii Arkhiv|January 1, 1993
[The possible approaches to the theoretical validation of the use of cytostatics and corticosteroids in treating glomerulonephritis]A A Ivanov, E M Shilov, O P Gladskikh, et al.
Klinicheskaia Meditsina|August 24, 2006
[Ischemic renal disease: clinical course, prognosis, possibilities of treatment]N A Mukhin, V V Fomin, S V Moiseev, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 7, 2007
[Genetic markers of predisposition to an aggressive course of chronic C hepatitis]S M Abdullaev, Iu I Tselishcheva, L M Samokhodskaia, et al.
Terapevticheskii Arkhiv|January 1, 1997
[Arterial hypertension in lupus nephritis]I E Tareeva, M Iu Shvetsov, T N Krasnova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Study of urinary markers of different podocytopathies by proteomic analysis]A A Vinogradov, N V Chebotareva, A E Bugrova, et al.
Terapevticheskii Arkhiv|July 23, 2013
[Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity]M G Galiamov, E A Saginova, M M Severova, et al.
Terapevticheskii Arkhiv|August 8, 1998
[Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis]T N Krasnova, E M Shilov, I E Tareeva, et al.
Pageof 4